Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Annovis Bio Inc
(NY:
ANVS
)
8.310
+0.280 (+3.49%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Annovis Bio Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Lawsuits Filed Against LIVE, ANVS and ATIP - Jakubowitz Law Pursues Shareholders Claims
August 20, 2021
NEW YORK, NY / ACCESSWIRE / August 20, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...
From
Jakubowitz Law
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of DIDI, ATVI and ANVS
August 20, 2021
NEW YORK, NY / ACCESSWIRE / August 20, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....
From
The Gross Law Firm
Via
AccessWire
Topics
Initial Public Offering
Lawsuit
Exposures
Financial
Legal
Securities Market
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BZ, CXO and ANVS
August 19, 2021
NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....
From
The Gross Law Firm
Via
AccessWire
ANNOVIS BIO SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Annovis Bio, Inc. - ANVS
August 19, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER ALERT: PHG ANVS ATIP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
August 19, 2021
NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...
From
The Law Offices of Vincent Wong
Via
AccessWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRAC, ATHA and ANVS
August 19, 2021
NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
CLASS ACTION UPDATE for RKT, BZ and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
August 19, 2021
NEW YORK, NY / ACCESSWIRE / August 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Annovis Bio, Inc. (ANVS)
August 19, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
ANNOVIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Annovis Bio, Inc. and Encourages Investors to Contact the Firm
August 18, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ANVS ALERT: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit
August 18, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 18, 2021
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ANVS
August 18, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Annovis Bio, Inc. (ANVS) Investors
August 18, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Annovis Bio, Inc. (ANVS) Investors
August 18, 2021
From
Law Offices of Howard G. Smith
Via
Business Wire
ANVS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Annovis Bio, Inc.
August 17, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
August 05, 2021
From
Law Offices of Howard G. Smith
Via
Business Wire
ANNOVIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Annovis Bio, Inc. on Behalf of Annovis Stockholders and Encourages Investors to Contact the Firm
August 03, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
August 03, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
August 03, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Annovis Bio, Inc.
August 02, 2021
From
Kirby McInerney LLP
Via
Business Wire
Annovis Bio to Present Data at Alzheimer's Association International Conference 2021 Highlighting Positive Clinical Outcomes from Its Two Phase 2a Trials
July 02, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - July 2, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Annovis Bio CEO Wins 2021 PACT Enterprise Award for Life Sciences and Healthcare CEO
July 01, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - July 1, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Annovis Bio CEO Selected as a Finalist in the 2021 PACT Enterprise Awards
June 24, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 24, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Annovis Bio to Present at 2021 BIO Digital
June 10, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 10, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Annovis Bio Expands Potential Application of ANVS401 to Infectious Diseases with New Preclinical Study
June 08, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 8, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a...
Via
Newsfile
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Annovis Bio to Present at Jefferies Virtual Healthcare Conference 2021
June 03, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 3, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Annovis Bio's ANVS401 Improves Speed and Accuracy in Alzheimer's and in Parkinson's Patients
June 01, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 1, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's...
Via
Newsfile
Annovis Bio Engages Global Executive Search Leader Spencer Stuart to Expand its Board and Management Team
May 28, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - May 28, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Exposures
Product Safety
Annovis Bio, Inc. Announces Closing of $50 Million Public Offering
May 27, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - May 27, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Annovis Bio, Inc. Announces Pricing of Public Offering
May 23, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - May 23, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.